Cargando…

Emerging agents that target signaling pathways in cancer stem cells

Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer; however, there are still no drugs targeting CSCs in clinical application. There are several signaling pathways playing critical roles in CSC progression, such as the Wnt, Hedgehog, Notch, Hippo, and autophag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yue, Li, Xiaoman, Wang, Ting, Guo, Qianqian, Xi, Tao, Zheng, Lufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249421/ https://www.ncbi.nlm.nih.gov/pubmed/32456660 http://dx.doi.org/10.1186/s13045-020-00901-6

Ejemplares similares

STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling
por: Zheng, Lufeng, et al.
Publicado: (2018)

MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
por: Gao, Lanlan, et al.
Publicado: (2019)

Transcriptional Factor Yin Yang 1 Promotes the Stemness of Breast Cancer Cells by Suppressing miR-873-5p Transcriptional Activity
por: Guo, Qianqian, et al.
Publicado: (2020)

Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
por: Silva, Valdenizia R., et al.
Publicado: (2021)

Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells
por: Zheng, Lufeng, et al.
Publicado: (2019)

Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells
por: Zheng, Lufeng, et al.
Publicado: (2019)

MicroRNA-9 as a paradoxical but critical regulator of cancer metastasis: Implications in personalized medicine
por: Liu, Yichen, et al.
Publicado: (2020)

MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis
por: Ni, Haiwei, et al.
Publicado: (2021)

The Role of Iron in Cancer Progression
por: Guo, Qianqian, et al.
Publicado: (2021)

Emerging Roles of RNF168 in Tumor Progression
por: Xie, Tianyuan, et al.
Publicado: (2023)

The roles and targeting options of TRIM family proteins in tumor
por: Zhang, Yuxin, et al.
Publicado: (2022)

STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer
por: Li, Xiaoman, et al.
Publicado: (2016)

RNA-binding proteins in tumor progression
por: Qin, Hai, et al.
Publicado: (2020)

Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
por: Zheng, Yue, et al.
Publicado: (2022)

Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
por: Koury, Jeffrey, et al.
Publicado: (2017)

Sulforaphane: An emergent anti-cancer stem cell agent
por: Coutinho, Leandro de Lima, et al.
Publicado: (2023)

Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
por: Borlongan, Mia C., et al.
Publicado: (2023)

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020)

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
por: Zhou, He-Ming, et al.
Publicado: (2021)

Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
por: Manni, Wang, et al.
Publicado: (2022)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023)

Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways
por: Cháirez-Ramírez, Manuel Humberto, et al.
Publicado: (2021)

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
por: Efremov, Dimitar G., et al.
Publicado: (2012)

Gentiopicroside promotes the osteogenesis of bone mesenchymal stem cells by modulation of β‐catenin‐BMP2 signalling pathway
por: Jiang, Huaji, et al.
Publicado: (2021)

Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions
por: Yang, Tinglin, et al.
Publicado: (2023)

Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells
por: Ponnurangam, Sivapriya, et al.
Publicado: (2015)

Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis
por: Iqbal, Waqas, et al.
Publicado: (2016)

Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells
por: Catara, Giuliana, et al.
Publicado: (2021)

Glioblastoma stem cells and Wnt signaling pathway: molecular mechanisms and therapeutic targets
por: Guan, Ruoyu, et al.
Publicado: (2020)

Cancer stem cell signaling pathways
por: Matsui, William H.
Publicado: (2016)

Effect of an low-energy Nd: YAG laser on periodontal ligament stem cell homing through the SDF-1/CXCR4 signaling pathway
por: Wu, Nan, et al.
Publicado: (2023)

Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells
por: Pan, Jing-Xuan, et al.
Publicado: (2012)

Targeting cancer stem cell pathways for cancer therapy
por: Yang, Liqun, et al.
Publicado: (2020)

Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells
por: Wang, Chen-Xi, et al.
Publicado: (2020)

The Hedgehog Signaling Pathway Emerges as a Pathogenic Target
por: Smelkinson, Margery G.
Publicado: (2017)

Corrigendum: Combinatorial Strategies to Target Molecularand Signaling Pathways to Disarm Cancer Stem Cells
por: Catara, Giuliana, et al.
Publicado: (2021)

Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells
por: Shen, Yao-An, et al.
Publicado: (2021)

Sensitivity Analysis of Intracellular Signaling Pathway Kinetics Predicts Targets for Stem Cell Fate Control
por: Mahdavi, Alborz, et al.
Publicado: (2007)

Cancer stem cells and signaling pathways in radioresistance
por: Chang, Lei, et al.
Publicado: (2015)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_obfecm5pubcbv854vhvhts1ic9